ProxyMiner / Company

IDEXX LABORATORIES INC /DEIDXX

Latest proxy: 2026 · view on SEC ↗ · CIK 0000874716

↓ Export PDF

← All companies

CEO total pay

$14,580,122

Jonathan J. Mazelsky · 2025

Say on pay

94%

Latest disclosed shareholder vote

CEO pay ratio

Item 402(u)

218 to 1

Median employee: $14,580,122

Compensation committee

CD&A

Compensation and Talent Committee

Per the latest proxy

Filings indexed: 2 · 2026 · 2025

Executive pay

What did they pay them?

From the Summary Compensation Table. Pay mix and YoY are computed from these rows.

Executive	Role	TotalYoY	Pay mix	Salary	Stock	Cash incentive	Other
Jonathan J. Mazelsky2025 compensation	President and Chief Executive Officer	$14,580,122↑ 12%	92% at-risk	$1,150,000	$5,399,881	$2,593,000	$37,240
Andrew Emerson2025 compensation	Executive Vice President and Chief Financial Officer	$3,033,071	82% at-risk	$531,146	$949,864	$577,500	$24,620
Brian P. McKeon2025 compensation	Former Executive Vice President, Chief Financial Officer and Treasurer	$351,680↓ 91%	0% at-risk	$293,404	—	—	$58,276
Michael J. Lane2025 compensation	Executive Vice President and General Manager, CAG Diagnostics Business Unit	$4,019,416↑ 8%	83% at-risk	$594,054	$1,349,855	$627,270	$98,288
Tina Hunt, PhDExecutive2025 compensation	Vice President, Global Strategy and Commercial	$3,945,293↑ 6%	84% at-risk	$594,054	$1,349,855	$627,270	$24,165
Martin Smith, PhDExecutive2025 compensation	Vice President and Chief Technology Officer, R&D, Global Operations, Information Technology and Information Security	$3,944,534↑ 6%	84% at-risk	$594,054	$1,349,855	$627,270	$23,406

Pay mix: base cash incentive equity other

Add to peer comparison →Year-over-year diff →

CD&A excerpt

Compensation discussion & analysis

Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.

This section describes the material elements of our executive compensation program, including our principal compensation practices and policies, details the oversight provided by the Compensation and Talent Committee over our executive compensation program and explains how we determined 2025 compensation for our NEOs. Our 2025 NEOs were as follows: NamePositionJonathan J. MazelskyPresident and CEOAndrew Emerson(1)Executive Vice President, Chief Financial Officer and TreasurerTina Hunt, PhD(2)Executive Vice President, Global Strategy and CommercialMichael J. Lane(3)Executive Vice President and General Manager, CAG Diagnostics Business UnitMartin Smith, PhD(4)Executive Vice President and Chief Technology Officer, R&D, Global Operations, Information Technology and Information SecurityBrian P. McKeon(1)Former Executive Vice President, Chief Financial Officer and Treasurer 1.Mr. Emerson succeeded Mr. McKeon as our Executive Vice President, Chief Financial Officer and Treasurer on March 1, 2025. Mr. McKeon subsequently served as Executive Vice President and Special Advisor until his June 1, 2025 retirement from IDEXX. 2.Dr. Hunt will cease serving in her role effective on April 13, 2026 …

Read the full CD&A on SEC.gov ↗

Peer comparison

Who they benchmark against

Click any peer to jump to their proxy. Peers we haven't ingested yet kick off an import on click.

2026 Compensation Peer Group
16 members · 3 in ProxyMiner
A · AGILENT TECHNOLOGIES, INC.ILMN · ILLUMINA, INC.ALGN · ALIGN TECHNOLOGY INCISRG · INTUITIVE SURGICAL INCBIO · BIO-RAD LABORATORIES, INC.MTD · METTLER TOLEDO INTERNATIONAL INC/COO · COOPER COMPANIES, INC.RVTY · REVVITY, INC.DXCM · DEXCOM INCRMD · RESMED INCEW · Edwards Lifesciences CorpSTE · STERIS plcELAN · Elanco Animal Health IncWAT · WATERS CORP /DE/Hologic, Inc.ZTS · Zoetis Inc.

Governance

Policy guardrails

hedging
prohibited
“and a prohibition against pledging and hedging activity.”
pledging
prohibited
“and a prohibition against pledging and hedging activity.”
clawback
present
“clawback policy”
stock ownership guidelines
present
“stock ownership guidelines”
change in control
In addition, each of the NEOs and certain other senior executives has a change in control agreement with IDEXX
“In addition, each of the NEOs and certain other senior executives has a change in control agreement with IDEXX”
compensation consultant
independent
“engages an independent compensation consultant, Farient, to inform and support its decisions on executive compensation”
compensation committee
Compensation and Talent Committee
“Compensation and Talent Committee”

Performance markers

Metric facts

revenue
$13.0
“(Diluted)ROIC(2)2025 Financial Performance Factor (%)2025 Achieved Results(3)9.6%$1,320.6$12.4948.3%2025 Target Goal(4)8.1%$1,307.7$12.2547.8%Variance to 2025 Target Goal(5)1.4%$13.0$0.240.5%Payout Rating(4)137.8%125.3%1…”
annual incentive payout
100%
“Under our 2025 annual performance-based cash bonus plan, applying our financial performance factor and our non-financial performance factor, as described above, the corporate factor was realized at 140% of target.”
ceo pay ratio
218 to 1
“of the ratio of (i) the total annual compensation of our CEO to (ii) the total annual compensation of our median employee. For fiscal year 2025: +the total annual compensation of our CEO was $14,580,122; +the total annua…”
median employee compensation
$14,580,122
“CEO Pay Ratio Pursuant to Item 402(u) of Regulation S-K, we are required to provide annual disclosure of the ratio of (i) the total annual compensation of our CEO to (ii) the total annual compensation of our median emplo…”
say on pay
94%
“votes cast voting in favor of approving the compensation of our NEOs.”

Ask

Anything about IDEXX LABORATORIES INC /DE’s 2026 proxy

Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.

Loading the Ask interface…